Atlas Trials

Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)

Clinical trial NCT02545842 · COMPLETED

Trial details

NCT number
NCT02545842
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2015-09-07
Primary completion
2018-04-20
Enrollment
947

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.